
Aviva has expanded into university spinout investing following an earlier investment in the University of Cambridge's affiliated fund, Cambridge Innovation Capital.
London universities are among the most prolific in the UK for producing spinouts but unlike Oxford and Cambridge, have lacked a single, dedicated organisation to promote spinout investment.
UK universities have also reduced their average equity stakes to new a new low.
Anchor investor Shanghai Industrial Investment targets opportunities in biomedical sectors, including neurodegeneration and gene therapy.
Half of the spinouts from the universities of Bath, Bristol, Cardiff, Exeter, Southampton and Surrey raised seed funding in 2024.
The London university has seen a surge in applications to commercialise artificial intelligence-related technologies.
With a £15m commitment, Aviva’s investment in Cambridge Innovation Capital’s new Opportunity Fund marks its continuing backing of the Cambridge startup ecosystem
The small German academic institution generates an outsize number of unicorns.